268 related articles for article (PubMed ID: 28236652)
1. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
[TBL] [Abstract][Full Text] [Related]
2. Volume dependence in hypoxia-targeted dose escalation.
Chvetsov AV; Zeng J; Rajendran JG
Med Phys; 2018 Nov; 45(11):5325-5331. PubMed ID: 30192391
[TBL] [Abstract][Full Text] [Related]
3. A radiobiological model of reoxygenation and fractionation effects.
Guerrero M; Carlson DJ
Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
[TBL] [Abstract][Full Text] [Related]
4. Volume effects in the TCP for hypoxic and oxygenated tumors.
Chvetsov AV; Stewart RD; Kim M; Meyer J; Rengan R
Med Phys; 2020 Sep; 47(9):4626-4633. PubMed ID: 32452034
[TBL] [Abstract][Full Text] [Related]
5. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
[TBL] [Abstract][Full Text] [Related]
6. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
Zhang H; Zhong H; Barth RF; Cao M; Das IJ
Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
[TBL] [Abstract][Full Text] [Related]
7. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
[TBL] [Abstract][Full Text] [Related]
8. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
9. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
10. Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes.
Chvetsov AV; Hanin LG; Stewart RD; Zeng J; Rengan R; Lo SS
Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34030139
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after Hypofractionation.
Zhang H; Wan C; Huang J; Yang C; Qin Y; Lu Y; Ma J; Wu B; Xu S; Wu G; Yang K
Radiat Res; 2018 Dec; 190(6):584-595. PubMed ID: 30234458
[TBL] [Abstract][Full Text] [Related]
12. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
Lindblom E; Dasu A; Toma-Dasu I
Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
[TBL] [Abstract][Full Text] [Related]
13. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
[TBL] [Abstract][Full Text] [Related]
14. A simple mathematical model of cyclic hypoxia and its impact on hypofractionated radiotherapy.
Taylor E
Med Phys; 2023 Mar; 50(3):1893-1904. PubMed ID: 36594511
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
Ruggieri R
Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
[TBL] [Abstract][Full Text] [Related]
16. Single-fraction simulation of relative cell survival in response to uniform versus hypoxia-targeted dose escalation.
Axente M; Lin PS; Pugachev A
Phys Med Biol; 2012 May; 57(9):2757-74. PubMed ID: 22507874
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
18. The radiobiology of hypofractionation.
Nahum AE
Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
[TBL] [Abstract][Full Text] [Related]
19. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
Ruggieri R; Nahum AE
Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
[TBL] [Abstract][Full Text] [Related]
20. A new approach to dose escalation in non-small-cell lung cancer.
Mehta M; Scrimger R; Mackie R; Paliwal B; Chappell R; Fowler J
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):23-33. PubMed ID: 11163494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
